3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
56
Ovarian Neoplasms
35
Carcinoma, Hepatocellular
35
Neoplasms
25
Fallopian Tube Neoplasms
20
Carcinoma, Non-Small-Cell Lung
19
Endometrial Neoplasms
13
Glioblastoma
11
Breast Neoplasms
11
Brain Neoplasms
11
Neoplasm Metastasis
9
Colonic Neoplasms
9
Lung Neoplasms
8
Uterine Cervical Neoplasms
7
Liver Neoplasms
7
Rectal Neoplasms
6
Glioma
6
Biliary Tract Neoplasms
6
Stomach Neoplasms
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Gastrointestinal Neoplasms
4
Digestive System Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Small Cell Lung Carcinoma
3
Sarcoma
3
Recurrence
3
Peritoneal Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Pancreatic Neoplasms
3
Interventions
Cyclophosphamide
5
Rituximab
4
Vincristine
3
Prednisone
3
Doxorubicin
3
Etoposide
2
venetoclax
1
pembrolizumab
1
liposomal doxorubicin
1
ibrutinib
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
acalabrutinib
1
Zidovudine
1
Whole-Body Irradiation
1
Valganciclovir
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Nivolumab
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Interferon-alpha
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
CLR1404
1
CA-4948
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoproliferative Disorders
×
Bevacizumab
×
90 days
×
Clear all
No trials found.